December 11, 2018 5:29pm
As my constructed coverage of 45 companies closes neutral with an Advance/Decline Line (A/DL) of 21/21 and 3 flats
There is just NO trust to the long side as short positions continue to rise as volume remains low with continuous volatility
Out and about: Does Biostage (BSTG - $0.49 or -16.34%) have interlocking financial interests and conflicts with a director, scientific advisor and the medical institution where research is taking place and where trials are to take place?
Investors should be reading about today’s final “figures” – be a subscriber and be ready for tomorrow’s session! As I have stated … today’s gold could be tomorrow’s tin!
Members only. Please login.